# Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features

> **NCT00314925** · PHASE1 · UNKNOWN · sponsor: **Neotropix** · enrollment: 60 (estimated)

## Conditions studied

- Carcinoid
- Neuroendocrine

## Interventions

- **DRUG:** Seneca Valley Virus (biological agent)

## Key facts

- **NCT ID:** NCT00314925
- **Lead sponsor:** Neotropix
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-04
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2010-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00314925

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00314925, "Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00314925. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*